GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Cyclically Adjusted Revenue per Share

GemVax & KAEL Co (XKRX:082270) Cyclically Adjusted Revenue per Share : ₩2,140.48 (As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

GemVax & KAEL Co's adjusted revenue per share for the three months ended in Mar. 2025 was ₩311.084. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,140.48 for the trailing ten years ended in Mar. 2025.

During the past 12 months, GemVax & KAEL Co's average Cyclically Adjusted Revenue Growth Rate was -13.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of GemVax & KAEL Co was 3.90% per year. The lowest was -46.90% per year. And the median was 0.05% per year.

As of today (2025-07-22), GemVax & KAEL Co's current stock price is ₩55300.00. GemVax & KAEL Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩2,140.48. GemVax & KAEL Co's Cyclically Adjusted PS Ratio of today is 25.84.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of GemVax & KAEL Co was 32.61. The lowest was 0.69. And the median was 5.73.


GemVax & KAEL Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for GemVax & KAEL Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Cyclically Adjusted Revenue per Share Chart

GemVax & KAEL Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,340.92 2,320.04 2,540.80 2,486.08 2,209.95

GemVax & KAEL Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,485.97 2,414.40 2,297.36 2,209.95 2,140.48

Competitive Comparison of GemVax & KAEL Co's Cyclically Adjusted Revenue per Share

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemVax & KAEL Co's Cyclically Adjusted PS Ratio Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Cyclically Adjusted PS Ratio falls into.


;
;

GemVax & KAEL Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, GemVax & KAEL Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=311.084/122.5900*122.5900
=311.084

Current CPI (Mar. 2025) = 122.5900.

GemVax & KAEL Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 541.453 100.051 663.431
201509 194.585 100.111 238.278
201512 711.269 100.220 870.027
201603 804.581 100.561 980.834
201606 746.650 100.791 908.138
201609 1,168.293 101.461 1,411.584
201612 -1,769.539 101.561 -2,135.930
201703 308.530 102.851 367.744
201706 512.587 102.611 612.389
201709 4,334.466 103.491 5,134.405
201712 -450.389 102.991 -536.098
201803 304.187 104.101 358.213
201806 333.354 104.130 392.449
201809 329.425 105.651 382.243
201812 464.621 104.351 545.831
201903 290.177 104.491 340.439
201906 248.456 104.881 290.408
201909 288.984 105.200 336.753
201912 355.253 105.121 414.288
202003 363.661 105.354 423.155
202006 451.219 105.112 526.249
202009 438.849 106.198 506.589
202012 417.560 105.765 483.983
202103 307.630 107.357 351.279
202106 418.365 107.579 476.743
202109 329.627 108.759 371.545
202112 453.169 109.676 506.526
202203 462.976 111.848 507.441
202206 925.740 114.072 994.864
202209 487.588 114.715 521.059
202212 310.197 115.179 330.156
202303 398.304 116.507 419.099
202306 624.564 117.182 653.387
202309 346.445 118.964 357.006
202312 463.994 118.837 478.647
202403 374.361 120.123 382.049
202406 427.681 120.007 436.885
202409 320.953 120.861 325.544
202412 460.514 121.135 466.045
202503 311.084 122.590 311.084

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


GemVax & KAEL Co  (XKRX:082270) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

GemVax & KAEL Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=55300.00/2140.48
=25.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of GemVax & KAEL Co was 32.61. The lowest was 0.69. And the median was 5.73.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


GemVax & KAEL Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


GemVax & KAEL Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines